Sintx Technologies Appoints New Chairman of the Board

SINTX Technologies, Inc. (NASDAQ:SINT), a medical device company with a market capitalization of $4.11 million, announced a change in its leadership structure earlier this week. On Monday, Eric K. Olson was appointed as the new Chairman of the Board of Directors. Olson, who joined the board on July 31, 2024, will be taking over from B. Sonny Bal, who has stepped down from the role but will continue to serve as a board member.

The transition in the company’s leadership comes as SINTX continues to focus on the development and commercialization of silicon nitride for medical and industrial applications. The company has shown revenue growth of 30.4% over the last twelve months, though InvestingPro analysis indicates challenges with cash burn and profitability. This change reflects the ongoing evolution of the company’s governance as it strives to align with its strategic goals.

Olson’s appointment is expected to bring fresh perspectives to SINTX’s boardroom discussions and decision-making processes. His previous experience and the knowledge gained since joining the board will be invaluable as the company navigates the competitive landscape of the medical devices sector.

The company’s SEC filing on March 13, 2025, confirms these changes, which took effect on March 7, 2025. The filing provides no further details on the compensatory arrangements for the new Chairman or any other potential shifts in the company’s executive suite.

Investors and stakeholders will be watching closely to see how Olson’s leadership will influence the company’s direction and performance in the coming months. With the company’s next earnings report due on March 27, 2025, and an InvestingPro Financial Health score of FAIR, the impact of its board’s composition and guidance remains a point of interest for those following the company’s progress.

This report is based on a press release statement and the information has been confirmed through a recent SEC filing by SINTX Technologies.

In other recent news, SINTX Technologies has successfully completed a private placement, raising approximately $5 million in gross proceeds. The offering involved selling shares and warrants, facilitated by H.C. Wainwright & Co., and the capital is intended for working capital purposes. The securities from this transaction are subject to resale restrictions unless registered with the SEC or exempted from such requirements. Additionally, SINTX Technologies announced the election of Mark Froimson, MD, as a Class I director for a three-year term during their annual stockholders meeting. The meeting also saw the approval of Tanner LLC as the independent registered public accounting firm for 2024. A non-binding resolution on executive compensation was approved, alongside an amendment to the 2020 Equity Incentive Plan, increasing the authorized shares by 333,650. Shareholders also supported a proposal allowing for potential adjournments of the annual meeting to solicit additional proxies if needed. These developments indicate active shareholder engagement in SINTX Technologies’ strategic and governance decisions.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.